Neurocrine Biosciences shares owned by Summit Global Investments
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Summit Global Investments
from 13F filings
Historical chart of Summit Global Investments investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Summit Global Investments consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Summit Global Investments
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.1M | 36k | 140.37 |
| 2025-06-30 | $1.4M | 12k | 125.65 |
| 2025-03-31 | $1.2M | 11k | 110.59 |
| 2024-12-31 | $4.4M | 32k | 136.49 |
| 2024-09-30 | $6.2M | 54k | 115.22 |
| 2024-06-30 | $11M | 78k | 137.67 |
| 2024-03-31 | $6.8M | 50k | 137.92 |
| 2023-12-31 | $5.4M | 41k | 131.76 |
| 2023-09-30 | $3.4M | 30k | 112.49 |
| 2023-06-30 | $2.8M | 30k | 94.29 |
| 2023-03-31 | $2.9M | 29k | 101.22 |
| 2022-12-31 | $3.2M | 27k | 119.43 |
| 2022-09-30 | $1.2M | 12k | 106.18 |